Chronic Rhinosinusitis clinical trials

Explore recruiting chronic rhinosinusitis clinical trials.

Recruiting chronic rhinosinusitis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Chronic Rhinosinusitis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Dupilumab treatment in patients with chronic rhinosinusitis with nasal polyps: the effect on comorbid eosinophilic otitis media

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

A double-blinded extension study to evaluate the long-term safety and tolerability of itepekimab in adult participants with inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP) who participated in either EFC18418 or EFC18419 clinical studies

Germany, Netherlands, Portugal, Denmark, Sweden, Finland +9 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Mepolizumab and in-office nasal polypectomy in patients with chronic rhinosinusitis (CRS). A three arm study.

Spain

Therapeutic use (Phase IV) EU CTIS Study details

English Title: Tapering of biologics in CRSwNP Subtitle: Tapering of Mepolizumab or Dupilumab after 12 months of complete or partial disease control in patients with severe chronic rhinosinusitis with nasal polyposis – a national Danish RCT.

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

Effect of Dupilumab on nasal epithelial barrier function in patients with Chronic Rhinosinusitis with nasal polyps (CRSwNP) – an exploratory pilot study

Austria

Therapeutic use (Phase IV) EU CTIS Study details

Patient reported efficacy of intranasal lysine-aspirin in controlling NSAID-exacerbated respiratory disease.

Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

Chronic Rhinosinusitis trials by city

Chronic Rhinosinusitis in Toronto Chronic Rhinosinusitis in Vancouver Chronic Rhinosinusitis in Montreal Chronic Rhinosinusitis in Calgary Chronic Rhinosinusitis in Edmonton Chronic Rhinosinusitis in Ottawa Chronic Rhinosinusitis in Winnipeg Chronic Rhinosinusitis in Quebec City Chronic Rhinosinusitis in Hamilton Chronic Rhinosinusitis in Kitchener Chronic Rhinosinusitis in London Chronic Rhinosinusitis in Halifax Chronic Rhinosinusitis in New York Chronic Rhinosinusitis in Los Angeles Chronic Rhinosinusitis in Chicago Chronic Rhinosinusitis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease